---
figid: PMC7308236__wjmh-38-359-g006
figlink: pmc/articles/PMC7308236/figure/F6/
number: Fig. 6
caption: . The proposed mechanism through which electric stimulation hyperthermia
  treatment (ESHT) improves prostatitis. With ESHT, levels of HSP70 and suppressor
  of cytokine signaling 3 (SOCS3) significantly increase, leading to binding and inhibition
  of the toll-like receptor 4 (TLR4)/MyD88 polymers. With the TLR4-nuclear factor
  kappa B (NF-κB) pathway blocked, the expression of NF-κB also decreases. Without
  the regulation by NF-κB in the nucleus, inflammatory cytokines, such as interleukin
  (IL)-1β, IL-6, IL-8, and tumor necrosis factor alpha (TNF-α) will not be generated
  by target cells.
pmcid: PMC7308236
papertitle: Electric Stimulation Hyperthermia Relieves Inflammation via the Suppressor
  of Cytokine Signaling 3-Toll Like Receptor 4 Pathway in a Prostatitis Rat Model.
reftext: Guan Qun Zhu, et al. World J Mens Health. 2020 Jul;38(3):359-369.
pmc_ranked_result_index: '34682'
pathway_score: 0.9581622
filename: wjmh-38-359-g006.jpg
figtitle: Electric Stimulation Hyperthermia Relieves Inflammation via the Suppressor
  of Cytokine Signaling 3-Toll Like Receptor 4 Pathway in a Prostatitis Rat Model
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7308236__wjmh-38-359-g006.html
  '@type': Dataset
  description: . The proposed mechanism through which electric stimulation hyperthermia
    treatment (ESHT) improves prostatitis. With ESHT, levels of HSP70 and suppressor
    of cytokine signaling 3 (SOCS3) significantly increase, leading to binding and
    inhibition of the toll-like receptor 4 (TLR4)/MyD88 polymers. With the TLR4-nuclear
    factor kappa B (NF-κB) pathway blocked, the expression of NF-κB also decreases.
    Without the regulation by NF-κB in the nucleus, inflammatory cytokines, such as
    interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor alpha (TNF-α) will
    not be generated by target cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR4
  - SOCS3
  - MYD88
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - CXCL8
  - IL1B
  - IL6
  - TNF
  - Co00000000d000000000000000000000po00000000
genes:
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: SoCS3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-1B,
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1B,IL-6,IL-8,TNF-a
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1B,IL-6,IL-8,TNF-a
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-1B,IL-6,IL-8,TNF-a
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-1B,IL-6,IL-8,TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
chemicals: []
diseases:
- word: Co00000000d000000000000000000000po00000000
  source: ''
  identifier: ''
---
